Plain-English translation of NCT06238310 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether mannitol and iohexol—two different marker substances—are equally reliable for measuring how well your kidneys are working. Researchers want to know if these two methods give similar results when measuring your kidney filtration rate, which is an important way to assess kidney health.
Accurately measuring kidney function is crucial for managing kidney disease, especially in hospital patients. This trial is trying to determine which measurement method is most reliable and trustworthy so doctors can use the best approach for their patients.
You will receive two injection boluses (one with each marker substance) on the same day, using the same measurement protocol. Blood samples will be collected at the start and three more times after each injection, following the standard schedule used at your hospital or clinic. The entire process takes just a few hours, and your results will be coded so they cannot be identified when published.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Sweden
Sponsor
Katalin Kiss
Collaborators
Göteborg University
Enrollment target
~40 participants
Started
August 2023
Primary completion
February 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Katalin Kiss
Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden